CURI vs FUBO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

CURI

45.9
AI Score
VS
FUBO Wins

FUBO

72.9
AI Score

Investment Advisor Scores

CURI

46score
Recommendation
HOLD

FUBO

73score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI FUBO Winner
Forward P/E 8.1766 169.4915 CURI
PEG Ratio 0 0 Tie
Revenue Growth 22.3% 38.0% FUBO
Earnings Growth 1400.0% 0.0% CURI
Tradestie Score 45.9/100 72.9/100 FUBO
Profit Margin 0.0% -1.0% CURI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CURI 1M: -13.9% · 3M: -13.9% FUBO 1M: -10.2% · 3M: -19.1%

Current Technical Phase

CURI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $2.41

FUBO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 43

RSI (14): 43.4 · Price: $7.85

Fundamentals Snapshot

Metric CURI FUBO
Market Cap — —
Forward P/E 7.8 17.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.2% 0.4%
Gross Margin 0.6% 0.1%
Operating Margin 0.4% 0.0%
EPS 0.00 -1.24
Dividend Yield 0.13% —

Frequently Asked Questions

Based on our detailed analysis, FUBO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.